SCHEMBL8963454

SCHEMBL8963454

CCCCCCCCCCCCc1ccc(NC)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.59
ADRA2A P08913 2/20 0.59
ADORA3 P0DMS8 2/20 0.59
TACR2 P21452 2/20 0.59
SLC6A2 P23975 2/20 0.59
SLC6A4 P31645 2/20 0.59
SLC6A3 Q01959 2/20 0.59
KDM4E B2RXH2 1/20 0.59
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.59
SHBG P04278 1/20 0.59
TP53 P04637 1/20 0.59
CYP3A4 P08684 1/20 0.59
HSPD1 P10809 1/20 0.59
ADRB3 P13945 1/20 0.59
HTR2C P28335 1/20 0.59
HSPE1 P61604 1/20 0.59
HIF1A Q16665 1/20 0.59
TST Q16762 1/20 0.59
HSD17B10 Q99714 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28152699 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL177483 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL19513921 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL15766189 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL4093509 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8963483 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL4083403 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL30468687 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL4089466 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2
SCHEMBL8963306 1.00 ESR1 (0.59) ESR1ADRA2AADORA3TACR2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037541-B2 Anionic-cationic-nonionic surfactant, production and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2024-07-16 US disclosed
US-20220033705-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2022-02-03 US disclosed
US-11186764-B2 Anionic-cationic-nonionic surfactant, production and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2021-11-30 US disclosed
US-20190330516-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2019-10-31 US disclosed
US-10400156-B2 Anionic-cationic-nonionic surfactant, production and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2019-09-03 US disclosed
CN-105642185-B A kind of anionic-cationic-nonionic surface active agent, its manufacturing method and its application 中国石油化工股份有限公司 2018-07-31 CN disclosed
US-20170313928-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2017-11-02 US disclosed
CN-105642185-A Anionic-cationic-nonionic surfactant, preparation method therefor and application of anionic-cationic-nonionic surfactant 中国石油化工股份有限公司 2016-06-08 CN disclosed
US-9028977-B2 Compound, method for preparing same and organic electronic device using same LG CHEM, LTD. (KR) 2015-05-12 US disclosed
US-8968884-B2 Compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2015-03-03 US disclosed
CN-1537874-A Polyaddition catalyst component, polyaddition catalyst and method for preparing addition polymer ס�ѻ�ѧ��ҵ��ʽ���� 2004-10-20 CN disclosed
CN-1537872-A Polyaddition catalyst component, polyaddition catalyst, and method for preparing addition polymer ס�ѻ�ѧ��ҵ��ʽ���� 2004-10-20 CN disclosed
CN-1537871-A Polyaddition catalyst component polyaddition catalyst and pruess for producing addition polymer ס�ѻ�ѧ��ҵ��ʽ���� 2004-10-20 CN disclosed
CN-1530378-A Catalyst component for polyaddition, catalyst and method for producing addition polymer ס�ѻ�ѧ��ҵ��ʽ���� 2004-09-22 CN disclosed
CN-1306011-A Polyaddition catalyst component, polyaddition catalyst and method for preparing addition polymer SUMITOMO CHEMICAL CO (JP) 2001-08-01 CN disclosed
EP-0705591-A2 Cyclic amidocarboxy surfactants, synthesis and use thereof STEPAN COMPANY (US) 1996-04-10 EP disclosed
EP-0486510-B1 CYCLIC AMIDOCARBOXY SURFACTANTS, SYNTHESIS AND USE THEREOF STEPAN CO (US) 1996-02-14 EP disclosed
EP-0688601-A1 Cyclic amidocarboxy surfactants, synthesis and use thereof STEPAN COMPANY (US) 1995-12-27 EP disclosed
EP-0486510-A1 CYCLIC AMIDOCARBOXY SURFACTANTS, SYNTHESIS AND USE THEREOF. STEPAN CO (US) 1992-05-27 EP disclosed
WO-1991001970-A2 CYCLIC AMIDOCARBOXY SURFACTANTS, SYNTHESIS AND USE THEREOF STEPAN COMPANY (US) 1991-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190330516-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF LIPA, ABHD12, ABHD16A ESR1 2837/4885ADRA2A 2849/4885ADORA3 1560/4885
US-12037541-B2 Anionic-cationic-nonionic surfactant, production and use thereof LIPA, SGMS1, AQP1 ESR1 2274/4885ADRA2A 2633/4885ADORA3 2948/4885
US-11186764-B2 Anionic-cationic-nonionic surfactant, production and use thereof LIPA, ABHD12, ABHD16A ESR1 2837/4885ADRA2A 2849/4885ADORA3 1560/4885
US-20220033705-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF LIPA, ABHD16A, ABHD12 ESR1 2216/4885ADRA2A 2736/4885ADORA3 1945/4885
US-10400156-B2 Anionic-cationic-nonionic surfactant, production and use thereof LIPA, ABHD12, ABHD16A ESR1 2837/4885ADRA2A 2849/4885ADORA3 1560/4885
US-20170313928-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF LIPA, ABHD12, ABHD16A ESR1 2837/4885ADRA2A 2849/4885ADORA3 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.